Cardiovascular Safety & Toxicity Evaluation Services

Assessment of drug safety and toxicity is complex and can be time consuming. Cardiac toxicity may be observed after short or long-term compound exposure. Additionally, structural and functional aspects of cardiac toxicity need to be considered. Uncovering potential cardiotoxic effects of drug candidates earlier in the drug discovery process will decrease drug attrition rates and saves needed resources. Ncardia provides integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates. All services utilize functional human iPSC-derived cell models in qualified assays.